May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Intravitreal Toxicity of Garenoxacin
Author Affiliations & Notes
  • J.T. DellaCroce
    Ophthalmology, Tulane Univ Health Sci Ctr, New Orleans, LA
  • M. Riazi Esfahani
    Ophthalmology, Tulane Univ Health Sci Ctr, New Orleans, LA
    Ophthalmology, Tehran University Eye Research Center, Tehran, Iran (Islamic Republic of)
  • A.A. Kazi
    Ophthalmology, Tulane Univ Health Sci Ctr, New Orleans, LA
    Ophthalmology, Isra University, Hyderabad, Pakistan
  • G.A. Peyman
    Ophthalmology, Tulane Univ Health Sci Ctr, New Orleans, LA
  • E. Aydin
    Ophthalmology, Tulane Univ Health Sci Ctr, New Orleans, LA
  • Footnotes
    Commercial Relationships  J.T. DellaCroce, None; M. Riazi Esfahani, None; A.A. Kazi, None; G.A. Peyman, None; E. Aydin, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5561. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.T. DellaCroce, M. Riazi Esfahani, A.A. Kazi, G.A. Peyman, E. Aydin; Intravitreal Toxicity of Garenoxacin . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5561.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To assess the retinal toxicity of various concentrations of intravitreally injected garenoxacin. Methods: Twenty eyes of twenty New Zealand albino rabbits were used for this study. The animals were anesthetized and treated in accordance with the ARVO statement for the use of animals in ophthalmic and visual research. Garenoxacin was titrated using distilled water to the following concentrations: 4000 µg/0.1 ml, 2000 µg/0.1 ml, 1000 µg/0.1 ml, 400 µg/0.1 ml, 200 µg/0.1 ml, and 100 µg/0.1 ml. Each of these concentrations was injected intravitreally (0.1 ml) into 3 rabbit eyes. Three eyes were used as control and received 0.1 ml of balanced salt solution. All animals were examined before and after injection using the indirect ophthalmoscope and slit–lamp biomicroscopy. Electroretinography (ERG) was performed on all animals prior to intravitreal injection and 14 days after injection. The animals were euthanized and the eyes were enucleated and examined with light microscopy. Results: No ERG changes or signs of retinal toxicity on slit–lamp examination, indirect ophthalmoscopy, or light microscopy were seen in any of the eyes 14 days after intravitreal injection of 4000 µg of garenoxacin or less. Conclusions: Garenoxacin injected intravitreally appears safe at concentrations of 4000 µg/0.1 ml or less. These doses are several times more than the minimum inhibitory concentration required for the most resistant Gram–positive endophthalmitis isolates and it may be considered as an efficient drug in treatment of bacterial endophthalmitis.

Keywords: antibiotics/antifungals/antiparasitics • retina • drug toxicity/drug effects 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.